Investor interest in companies with obesity candidates in their pipeline clearly remains high, given that a brand new ...
Financing was co-led by Forbion and General Atlantic, with participants including RA Capital Management, OrbiMed, and Lilly Asia Ventures.
Danish drugmaker Novo Nordisk and U.S. tech firm Valo Health said on Wednesday they were expanding their 2023 agreement to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback